SCHEMBL3479808

SCHEMBL3479808

CN1CCN(c2ccc(Cl)cc2)c2ccc(-c3nncs3)cc2C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 1/20 0.41
WNT1 P04628 4/20 0.38
GSK3B P49841 4/20 0.38
DYRK1A Q13627 4/20 0.38
BRD4 O60885 7/20 0.36
HRH4 Q9H3N8 2/20 0.35
HTR6 P50406 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
BRD2 P25440 6/20 0.35
POLB P06746 1/20 0.34
BRD3 Q15059 5/20 0.34
MAPKAPK2 P49137 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
KMT2A Q03164 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3227589 0.89 SCN9A (0.43) SCN9AWNT1GSK3BDYRK1AHRH4
SCHEMBL3234570 0.89 SCN9A (0.42) SCN9AWNT1GSK3BDYRK1ABRD4
SCHEMBL3230724 0.87 SCN9A (0.40) SCN9AWNT1GSK3BDYRK1AKMT2A
SCHEMBL3236820 0.85 SCN9A (0.39) SCN9AWNT1GSK3BDYRK1AHRH4
SCHEMBL3232390 0.84 HTR3A (0.41) SCN9AWNT1GSK3BDYRK1AHRH4
SCHEMBL3232833 0.83 SCN9A (0.41) SCN9ABRD4HRH4HTR6HRH3
SCHEMBL3479957 0.80 SCN9A (0.41) SCN9ABRD4HRH4HTR6HRH3
SCHEMBL3240462 0.78 SCN9A (0.46) SCN9ABRD4HRH4HTR6HRH3
SCHEMBL3230176 0.78 SCN9A (0.49) SCN9ABRD4HRH4HTR6HRH3
SCHEMBL3479969 0.78 SCN9A (0.41) SCN9ABRD4HRH4HTR6HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9096546-B2 Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin ALBANY MOLECULAR RESEARCH, INC. (US) 2015-08-04 US disclosed
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ALBANY MOLECULAR RESEARCH, INC. (US) 2010-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137287-A1 ARYL-AND HETEROARYL-SUBSTITUTED TETRAHYDROBENZO-1,4-DIAZEPINES AND USE THEREOF TO BLOCK REUPTAKE OF NOREPINEPHRINE, DOPAMINE, AND SEROTONIN ADRA1B, ADRB1, ADRA1D SCN9A 795/4885WNT1 2258/4885GSK3B 1378/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.